- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.93 Å
- Oligo State
- monomer
- Ligands
- 3 x MG: MAGNESIUM ION(Non-covalent)
- 1 x SO4: SULFATE ION(Non-functional Binders)
- 6 x CL: CHLORIDE ION(Non-functional Binders)
CL.5: 2 residues within 4Å:- Chain A: R.101, K.105
Ligand excluded by PLIPCL.6: 3 residues within 4Å:- Chain A: R.61, V.160, H.161
Ligand excluded by PLIPCL.7: 2 residues within 4Å:- Chain A: K.220, E.226
Ligand excluded by PLIPCL.8: 1 residues within 4Å:- Chain A: R.238
Ligand excluded by PLIPCL.9: 1 residues within 4Å:- Chain A: G.54
Ligand excluded by PLIPCL.10: 1 residues within 4Å:- Chain A: R.224
Ligand excluded by PLIP- 4 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.11: 2 residues within 4Å:- Chain A: Y.100, E.141
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:E.141
- pi-Cation interactions: A:Y.100
DMS.12: 2 residues within 4Å:- Chain A: Y.215, Q.216
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Q.216
DMS.13: 4 residues within 4Å:- Chain A: L.11, V.44, R.86, Y.88
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.86
- Water bridges: A:Y.29
DMS.14: 4 residues within 4Å:- Chain A: G.236, P.262, W.263
- Ligands: GOL.21
2 PLIP interactions:2 interactions with chain A- Water bridges: A:G.236, A:N.267
- 2 x ACT: ACETATE ION(Non-functional Binders)
ACT.15: 4 residues within 4Å:- Chain A: S.126, M.254, L.255, R.256
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:M.254, A:R.256
- Hydrogen bonds: A:R.256
- Water bridges: A:H.129, A:L.255
- Salt bridges: A:R.256
ACT.16: 4 residues within 4Å:- Chain A: R.132, D.188, E.189, K.190
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:E.189
- Hydrogen bonds: A:E.189
- Water bridges: A:E.189
- Salt bridges: A:R.132
- 1 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
ADP.17: 19 residues within 4Å:- Chain A: L.20, G.21, K.22, G.23, K.24, V.28, A.41, K.43, L.75, E.92, A.94, T.98, E.141, N.142, L.144, D.155
- Ligands: MG.1, MG.2, T5L.18
17 PLIP interactions:17 interactions with chain A- Hydrogen bonds: A:K.24, A:E.92, A:A.94, A:D.155
- Water bridges: A:K.22, A:K.22, A:F.25, A:T.98, A:T.98, A:E.141, A:E.141, A:N.142, A:D.155, A:D.155, A:D.155
- Salt bridges: A:K.43, A:K.43
- 1 x T5L: (1~{R},2~{R})-cyclohexane-1,2-dicarboxylic acid
T5L.18: 12 residues within 4Å:- Chain A: F.25, K.43, L.45, V.55, Q.58, L.59, E.62, D.155, G.157, W.158
- Ligands: MG.2, ADP.17
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:F.25, A:V.55, A:Q.58
- Hydrogen bonds: A:E.62
- Water bridges: A:F.25, A:G.157, A:W.158
- Salt bridges: A:K.43, A:K.43
- 5 x GOL: GLYCEROL(Non-functional Binders)
GOL.19: 3 residues within 4Å:- Chain A: L.106, S.107, K.108
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:L.106
- Water bridges: A:D.110
GOL.20: 4 residues within 4Å:- Chain A: D.83, A.84, T.85, R.86
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:D.83, A:A.84, A:T.85, A:T.85, A:R.86
- Water bridges: A:D.83
GOL.21: 5 residues within 4Å:- Chain A: D.239, R.243, H.261, P.262
- Ligands: DMS.14
No protein-ligand interaction detected (PLIP)GOL.22: 5 residues within 4Å:- Chain A: K.47, A.48, E.51, A.84
- Ligands: T0L.24
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:A.48, A:A.84
GOL.23: 5 residues within 4Å:- Chain A: R.60, V.63, E.64, Y.80
- Ligands: T0L.24
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:E.64, A:Y.80
- Water bridges: A:R.60, A:R.60
- 1 x T0L: 4-(4-chloranyl-3-cyano-phenyl)-1~{H}-indole-6-carboxylic acid
T0L.24: 11 residues within 4Å:- Chain A: K.47, L.50, E.51, L.59, V.63, Y.80, F.81, H.82, V.87
- Ligands: GOL.22, GOL.23
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:K.47, A:L.50, A:L.59, A:H.82, A:V.87, A:V.87
- Hydrogen bonds: A:E.51, A:E.51
- Water bridges: A:K.47
- Salt bridges: A:K.47, A:H.82
- pi-Stacking: A:H.82
- pi-Cation interactions: A:K.47
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Stockwell, S.R. et al., Selective Aurora A-TPX2 Interaction Inhibitors Have In Vivo Efficacy as Targeted Antimitotic Agents. J.Med.Chem. (2024)
- Release Date
- 2024-01-10
- Peptides
- Aurora kinase A: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.93 Å
- Oligo State
- monomer
- Ligands
- 3 x MG: MAGNESIUM ION(Non-covalent)
- 1 x SO4: SULFATE ION(Non-functional Binders)
- 6 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 2 x ACT: ACETATE ION(Non-functional Binders)
- 1 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 1 x T5L: (1~{R},2~{R})-cyclohexane-1,2-dicarboxylic acid
- 5 x GOL: GLYCEROL(Non-functional Binders)
- 1 x T0L: 4-(4-chloranyl-3-cyano-phenyl)-1~{H}-indole-6-carboxylic acid
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Stockwell, S.R. et al., Selective Aurora A-TPX2 Interaction Inhibitors Have In Vivo Efficacy as Targeted Antimitotic Agents. J.Med.Chem. (2024)
- Release Date
- 2024-01-10
- Peptides
- Aurora kinase A: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A